The Wall Street Journal @WSJ
The U.S.’s supply of an antibody drug found to reduce the risk of severe Covid-19 disease could run out in August, and sales could shift to the commercial market unless Congress agrees on more pandemic funding https://t.co/VgYCsv3eEp — PolitiTweet.org